• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Frontiers in Medicinal Chemistry - Online

    Frontiers in Medicinal Chemistry - Online

    JournalISSN 1567-2042

    年发文量

    研究主题

    论文(123)

    排序
    1Contemporary Trends in Drug Repurposing: Identifying New Targets for Existing Drugs
    Srikant Bhagat,,Asim Kumar, Gaurav Joshi

    Drug repurposing or drug repositioning has emerged as an efficient, very popular and alternative technique in modern drug discovery to identify old drugs for new targets cost-effectively and dynamically. This concept gets a tremendous boost, especially in the century's most challenging healthcare concern of the Covid-19 pandemic across the globe. In this approach, scientists seek new indications and clinical use of the drugs at minimum risk, which have previously already been pharmacologically established and approved. The methods developed for drug repositioning include computational approaches and biological methodologies, and with the fast technological advancement, various new drug-target- diseases are discovered, and thereby immense information is now available in the different databases, such as DrugBank, OMIM, ChemBank, KEGG, Pubmed, Genecard, and many more. The information available on all the above public domain databases has been utilized successfully in many drug repositioning projects. The present chapter discusses the concept of drug repurposing and its impact on academia, industries and, of course, their social implications. Besides this, the chapter will also cover details on tools and techniques to identify drugs for repositioning and their application in identifying drugs for various diseases and disorders. The current work will also foresee the recent market analysis and updates on the cost of drug discovery and development by drug repurposing, its comparison with traditional drug discovery approaches, challenges involved with drug repurposing, and future perspectives.

    2023
    引用
    AI阅读
    加入学术空间
    2Medicinal Plants: A Future of Modern Medical System
    Aakansha Singh,Anjani Kumar

    Humans, since their evolution, have always been in close contact with mother nature. Early life has been dependent solely on environmental resources for their livelihood. The trial-and-error approach in utilizing different resources came up with incorporating plants as a whole or their parts for food and survival. Gradually, the knowledge of medicinal plants was gained by our ancestors, and there started the Indian medical history of Ayurveda. In the current scenario, a huge number of medicinal herbs are being consumed in day-to-day life, which imparts tremendous benefits to human health. Our interest in gaining knowledge of medicinal components present in these herbs has led to many important discoveries in the area of drug development. Nowadays, numerous plants derived compounds are being used in modern medicines. In view of utilizing these natural resources efficiently, we need to understand their components in a better way. This chapter is towards gaining a deeper knowledge about medicinal plants, their role in different diseases, and insights into drug discovery.<br>

    2023引用:1
    引用
    AI阅读
    加入学术空间
    3Isoxazole Derivatives As Potential Pharmacophore for New Drug Development
    Biswa Mohan Sahoo,Bera Venkata Varaha Ravi Kumar,Krishna Chandra Panda,Bimal Krishna Banik,Abhishek Tiwari,Varsha Tiwari,Sunil Singh,Manish Kumar

    Isoxazoles are five-membered aromatic heterocyclic compounds in which oxygen and nitrogen atoms are present at positions 1 and 2 of the ring system. Isoxazole derivatives play a vital role due to their diverse biological activities, such as antimicrobial, antifungal, anti-viral, anti-tubercular, anti-epileptic, anti-diabetic, anticancer, anthelmintic, antioxidant, antipsychotic, antimalarial, analgesic, anti-inflammatory, etc. Isoxazole scaffold is present in various drug molecules, such as leflunomide (antirheumatic), valdecoxib (non-steroidal anti-inflammatory drug), and zonisamide (anti-convulsant). Similarly, isoxazole derivatives such as isocarboxazid act as monoamine oxidase inhibitors. It is used to treat symptoms of depression that may include anxiety, panic, or phobias. Whereas the isoxazole derivatives, including sulfamethoxazole, sulfisoxazole, and oxacillin, are used clinically for the treatment of bacterial infections. Isoxazole pharmacophore is also present in β-lactamase resistant antibiotics such as cloxacillin, dicloxacillin, and flucloxacillin. Cycloserine is a naturally occurring antibiotic that possesses isoxazole moiety with anti-tubercular, activity. This study focuses on the therapeutic potentials of isoxazole derivatives in new drug development.

    2023
    引用
    AI阅读
    加入学术空间
    4Drugs and Phytochemicals Targeting Cancer
    Garima Tripathi,Anil Kumar Singh,Abhijeet Kumar

    Cancer which is basically uncontrolled cell division and, thereby, the formation of tumors, has been a prominent cause of death across the world. More than 10 million people have lost their lives due to different types of cancer such as breast, lung, prostate, gastrointestinal, etc. Several pathways, including metabolic, signalling, etc., get altered to support uncontrolled cell division and their growth in case of cancer. Despite an increasing understanding of this disease over the period of time, still, specific causes could not be held responsible for the occurrence. Therefore, various different strategies mainly focused on preventing and killing cancerous cells have been explored. This chapter will primarily focus on the different drugs, including different types of chemotherapeutic agents such as DNA-alkylating agents like nitrogen mustard, cyclophosphamide, drug-peptide, drug-steroid conjugates, antimetabolites, antibiotics, etc. In addition to that, phytochemicals, which have also been investigated for their anti-cancerous activities and are under clinical trial, have also been discussed.

    2023
    引用
    AI阅读
    加入学术空间
    5Harnessing the Neurological Properties of Indian Brain Health Booster Brahmi
    Neerja Tiwari, Manju Singh,Namita Gupta, Kishan Singh, Kapil Dev

    Brahmi (Bacopa monnieri Linn.) is a well-known therapeutic herb used in a broad spectrum of conventional medicines to alleviate various ailments, prominently those involving intellect, anxiety and mental health. In Ayurveda, it is classified as Medhya rasayanas (meaning intellect rejuvenator) and claimed to be a cognitive nutrient and memory enhancer. Although the plant possesses a plethora of compounds, its neurological activity is mainly attributed to its major phytochemical constituents, i.e., bacoside saponins. Majorly isolated compounds are dammarane triterpenoids glycone and aglycones. There are several reports published with neurological activities on Bacopa monnieri to validate traditional claims through scientific findings. Some therapeutic formulations containing standardized extracts of Bacopa monnieri have also been developed for the betterment of mental health. Besides, being neuroprotective, the plant is reported to possess anti-inflammatory, analgesic, and antipyretic properties and systemic disorders like cardiovascular, hepatic, gastrointestinal, myocardial ischemia, respiratory problems, opioid-related nephrotoxicity and hepatotoxicity. The present chapter described the phytochemical profiling, extraction and isolation, neurological properties, as well as toxicological and clinical studies of the plant.

    2023
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 123 篇论文

    高被引作者

    作者引用发文
    Hartmuth C. Kolb10431
    Beat Ernst10431
    O. Schwardt10431
    Avdeef Alex6231
    Luca Costantino4911
    Daniela Barlocco4911
    Somsák László4461
    Jyotsna Mishra2621
    Sarman Singh2621
    Anubha Saxena2621

    高产作者

    作者引用发文
    Allen B. Reitz485
    Atta-ur-Rahman03
    M. Iqbal Choudhary03
    Ravi S Singh02
    Gary W. Caldwell162
    E Matteucci2092
    Ottavio Giampietro2092
    AS MANKIN1821
    Diego Munoz-Torrero Lopez-Ibarra2461
    Jos Prickaerts1831

    相关期刊

    Biofactors
    Current pharmaceutical design
    Iubmb Life
    Journal of medicinal food
    Postepy higieny i medycyny doswiadczalnej (Online)
    Expert opinion on therapeutic patents
    Journal of clinical biochemistry and nutrition
    Recent patents on endocrine, metabolic & immune drug discovery
    AIMS molecular science
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease